Global Animal Biotechnology Market Professional Survey Report 2019

Animal biotechnology refers to the branch of biotechnology, which deals with the molecular biology techniques for producing genetically engineered animals (whose genome are modified), in order to make them suitable for pharmaceutical, industrial or agricultural applications. The genetically modified animals have improved growth rates, synthesized therapeutic proteins, and are resistant to various diseases. Increasing R&D by the major market players, rising regulatory approvals, and the rising focus toward cloning and transgenic animals are contributing to the market growth. However, high cost of research and development, and the ethical issues associated with animal biotechnology products may adversely affect the market growth.

The global Animal Biotechnology market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Animal Biotechnology volume and value at global level, regional level and company level. From a global perspective, this report represents overall Animal Biotechnology market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Animal Biotechnology in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Animal Biotechnology manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Bayer AG
Merck &, Inc.
Pfizer, Inc.
Sanofi
Biogenesis Bago
Santa Cruz Biotechnology, Inc.
Boehringer Inghlem
Virbac Inc.
Zoetis

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Diagnostic Tests
Drugs
Reporductive & Genetic Produtcs
Vaccines

Segment by Application
Preventive Care for Animals
Development of Animal Pharmaceuticals
Food Safety and Drug Development
Others